[1]
U. Costabel, “Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis”, Sarcoidosis VDLD, vol. 31, no. 3, pp. 198–205, Oct. 2014.